Espee Group

Schaumburg, USA
Espee Group is engaged in clinical trials and bioequivalence studies support.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Espee Group

Espee Group is a company based in Schaumburg, USA. It operates as a Professional Services. Espee Group offers products and services including Clinical Trials Support and Bioequivalence Studies. Espee Group operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

  • Headquarter Schaumburg, USA
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Espee Pharma (Uk) Limited
Operational Areas
Healthcare → Healthcare Education, Research & Associations
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Espee Group

Espee Group offers a comprehensive portfolio of products and services, including Clinical Trials Support and Bioequivalence Studies.

Primary

Support for clinical trials is provided to innovators.

Services for bioequivalence studies are offered to clients.

Funding Insights of Espee Group

Investments & Acquisitions by Espee Group

Investments

Financial Statements - Espee Group

Espee Group Comparisons

+
Add Comparison
Available on Premium

Competitors of Espee Group

Espee Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Integrated CDMO services for biopharma R&D and manufacturing are offered.
domain founded_year HQ Location
APIs manufacturing and formulation services are provided in therapeutic segments.
domain founded_year HQ Location
APIs and enzymes are manufactured through fermentation by the CDMO.
domain founded_year HQ Location
APIs and finished products are developed and manufactured.
domain founded_year HQ Location
Generic biocatalytic solutions are provided for pharmaceutical applications.
domain founded_year HQ Location
APIs and peptides are developed and manufactured by Asymchem.

Latest news on Espee Group

Frequently Asked Questions about Espee Group

Espee Group is involved in providing specialized distribution and services for clinical trials and bioequivalence studies. Support is extended to innovators, multinational generic manufacturers, and CROs across more than 25 countries on 6 continents. Solutions include reliable supply chains, economical sourcing, and project assurance through dedicated management. The focus is placed on RD and regulatory compliance in the healthcare and pharmaceutical sectors.

Espee Group's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

Espee Group offers Clinical Trials Support and Bioequivalence Studies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available